A validation study of new risk grouping criteria for postoperative treatment in stage IB cervical cancers without high-risk factors: rethinking the Gynecologic Oncology Group criteria.

Source:http://linkedlifedata.com/resource/pubmed/id/19695765

Download in:

View as

General Info

PMID
19695765